• 1
    Soulié M, Straub M, Gamé X et al. A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer. J Urol 2002; 167: 13251328
  • 2
    Novotny V, Hakenberg OW, Wiessner D et al. Perioperative complications of radical cystectomy in a contemporary series. Eur Urol 2007; 51: 397402
  • 3
    Svatek RS, Fisher MB, Matin SF et al. Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. J Urol 2010; 183: 929934
  • 4
    Bostrom PJ, Kossi J, Laato M et al. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int 2009; 103: 191196
  • 5
    Chang SS, Cookson MS, Baumgartner RG et al. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 2002; 167: 20122016
  • 6
    Hollenbeck BK, Miller DC, Taub D et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005; 174: 12311237
  • 7
    Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology 2006; 68: 5864
  • 8
    Lowrance WT, Rumohr JA, Chang SS et al. Contemporary open radical cystectomy: analysis of perioperative outcomes. J Urol 2008; 179: 13131318
  • 9
    Shabsigh A, Korets R, Vora KC et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009; 55: 164174
  • 10
    Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol 2010; 184: 990994
  • 11
    Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 1996; 93: 22122245
  • 12
    Japanese Circulation Society. Guidelines for the diagnosis,treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2004). J Cardiol 2005; 45: 349366
  • 13
    Matsumoto T, Kiyota H, Matsukawa M et al. Japanese guidelines for prevention of perioperative infections in urological field. Int J Urol 2007; 14: 890909
  • 14
    Fearon KC, Ljungqvist O, Von Meyenfeldt M et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 2005; 24: 466477
  • 15
    Donat SM. Standards for surgical complication reporting in urologic oncology: time for a change. Urology 2007; 69: 221225
  • 16
    Kubo M, Kiyohara Y, Kato I et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34: 23492354
  • 17
    Kitabatake A. Guidelines for the primary prevention of ischemic heart disease revised version. Circ J Suppl 2006; 19
  • 18
    Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383390
  • 19
    Wolf PA, D'Agostino RB, Kannel WB et al. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988; 259: 10251029
  • 20
    Iwai A, Koga F, Fujii Y et al. Perioperative complications of radical cystectomy after induction chemoradiotherapy in bladder-sparing protocol against muscle-invasive bladder cancer: a single institutional retrospective comparative study with primary radical cystectomy. Jpn J Clin Oncol 2011; 41: 13731379
  • 21
    Pycha A, Comploj E, Martini T et al. Comparison of complications in three incontinent urinary diversions. Eur Urol 2008; 54: 825832
  • 22
    Kilciler M, Bedir S, Erdemir F et al. Comparison of ileal conduit and transureteroureterostomy with ureterocutaneostomy urinary diversion. Urol Int 2006; 77: 245250
  • 23
    Barbieri CE, Lee B, Cookson MS et al. Association of procedure volume with radical cystectomy outcomes in a nationwide database. J Urol 2007; 178: 14181421
  • 24
    Ikeda N, Saito E, Kondo N et al. What has made the population of Japan healthy? Lancet 2011; 378: 10941105
  • 25
    Grossman H, Natale R, Tangen C et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859866
  • 26
    Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 202205
  • 27
    Shariat SF, Karakiewicz PI, Palapattu GS et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006; 176: 24142422
  • 28
    Yafi FA, Aprikian AG, Chin JL et al. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int 2011; 108: 539545
  • 29
    von der Maase H, Hansen SW, Roberts JT et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000; 18: 30683077
  • 30
    Dash A, Pettus JA, Herr HW et al. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer 2008; 113: 24712477